{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,3,5]],"date-time":"2025-03-05T05:33:44Z","timestamp":1741152824496,"version":"3.38.0"},"reference-count":7,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,4,25]],"date-time":"2024-04-25T00:00:00Z","timestamp":1714003200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,4,25]],"date-time":"2024-04-25T00:00:00Z","timestamp":1714003200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neurosurg Rev"],"DOI":"10.1007\/s10143-024-02428-7","type":"journal-article","created":{"date-parts":[[2024,4,25]],"date-time":"2024-04-25T11:01:37Z","timestamp":1714042897000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Does the role of non-coding RNA FAM131B-AS2 in glioblastoma go beyond the ATR pathway? A correspondence"],"prefix":"10.1007","volume":"47","author":[{"given":"Mohamed","family":"Jalloh","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Oluwafeyisola","family":"Osifala","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Samuel Berchi","family":"Kankam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Olayinka","family":"Fakorede","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,4,25]]},"reference":[{"key":"2428_CR1","doi-asserted-by":"crossref","unstructured":"Wang S, Qi Y, Zhao R, Pan Z, Li B, Qiu W, Zhao S, Guo X, Ni S, Li G, Xue H Copy number gain of FAM131B-AS2 promotes the progression of glioblastoma by mitigating replication stress. Neuro-oncology 2024 Jan 29:noae014","DOI":"10.1093\/neuonc\/noae014"},{"issue":"1","key":"2428_CR2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s10143-024-02348-6","volume":"47","author":"M Jalloh","year":"2024","unstructured":"Jalloh M, Kankam SB, Osifala O (2024) Could the combination of immunotherapy and target therapy be a potential double edge sword for glioblastoma treatment? A correspondence. Neurosurg Rev 47(1):1\u20132","journal-title":"Neurosurg Rev"},{"key":"2428_CR3","doi-asserted-by":"publisher","first-page":"e548","DOI":"10.1016\/j.wneu.2023.05.101","volume":"176","author":"M Shafizadeh","year":"2023","unstructured":"Shafizadeh M, Farzaneh F, Kankam SB, Jangholi E, Shafizadeh Y, Khoshnevisan A (2023) Effects of postoperative intravenous cyclosporine treatment on the survival and functional performance status of patients with glioblastoma: a randomized, triple-blinded, placebo-controlled clinical trial. World Neurosurg 176:e548\u2013e556","journal-title":"World Neurosurg"},{"key":"2428_CR4","unstructured":"Jalloh M, Kankam SB Harnessing imaging biomarkers for glioblastoma metastasis diagnosis: a correspondence. J Neuro-Oncology 2024 Feb 23:1\u20133"},{"issue":"4","key":"2428_CR5","first-page":"648","volume":"25","author":"I Korovina","year":"2023","unstructured":"Korovina I, Vehlow A, Temme A, Cordes N (2023) Targeting integrin \u03b12 as potential strategy for radiochemosensitization of glioblastoma. Neurooncology 25(4):648\u2013661","journal-title":"Neurooncology"},{"issue":"1","key":"2428_CR6","first-page":"104","volume":"12","author":"AP Kyritsis","year":"2010","unstructured":"Kyritsis AP, Bondy ML, Rao JS, Sioka C (2010) Inherited predisposition to glioma. Neurooncology 12(1):104\u2013113","journal-title":"Neurooncology"},{"issue":"1","key":"2428_CR7","first-page":"123","volume":"25","author":"A Omuro","year":"2023","unstructured":"Omuro A, Brandes AA, Carpentier AF, Idbaih A, Reardon DA, Cloughesy T, Sumrall A, Baehring J, van den Bent M, B\u00e4hr O, Lombardi G (2023) Radiotherapy combined with nivolumab or temozolomide for newly diagnosed glioblastoma with unmethylated MGMT promoter: an international randomized phase III trial. Neurooncology 25(1):123\u2013134","journal-title":"Neurooncology"}],"container-title":["Neurosurgical Review"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10143-024-02428-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10143-024-02428-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10143-024-02428-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,4]],"date-time":"2025-03-04T10:45:22Z","timestamp":1741085122000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10143-024-02428-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4,25]]},"references-count":7,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["2428"],"URL":"https:\/\/doi.org\/10.1007\/s10143-024-02428-7","relation":{},"ISSN":["1437-2320"],"issn-type":[{"type":"electronic","value":"1437-2320"}],"subject":[],"published":{"date-parts":[[2024,4,25]]},"assertion":[{"value":"13 April 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 April 2024","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 April 2024","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 April 2024","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"(Applicable for both human and\/ or animal studies. Ethical committees, Internal Review Boards and guidelines followed must be named. When applicable, additional headings with statements on consent to participate and consent to publish are also required): Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"192"}}